SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
226
Pacira BioSciences
PCRX
$1.19B
|
AF
Ami Fadia
| $26.45 | $75 |
184%
upside
| Market Perform | 4 years ago |
|
227
UnitedHealth
UNH
$286B
|
ST
Stephen Tanal
| $315.39 | $390 |
24%
upside
| Outperform | 4 years ago |
|
228
CVS Health
CVS
$93.6B
|
ST
Stephen Tanal
| $73.78 | $80 |
8%
upside
| Market Perform | 4 years ago |
|
229
Centene
CNC
$14.2B
|
ST
Stephen Tanal
| $28.98 | $75 |
159%
upside
| Outperform | 4 years ago |
|
230
Cigna
CI
$81.5B
|
ST
Stephen Tanal
| $305.31 | $240 |
21%
downside
| Market Perform | 4 years ago |
|
231
Ardelyx
ARDX
$1.57B
| $6.52 | $14 |
115%
upside
| Outperform | 4 years ago |
|
|
232
Keros Therapeutics
KROS
$633M
|
TS
Thomas Smith
| $15.59 | $80 |
413%
upside
| Outperform | 4 years ago |
|
233
AdaptHealth
AHCO
$1.29B
|
ST
Stephen Tanal
| $9.51 | $39.50 |
315%
upside
| Outperform | 4 years ago |
|
234
Humana
HUM
$37B
|
ST
Stephen Tanal
| $307.92 | $500 |
62%
upside
| Outperform | 4 years ago |
|
235
Amneal Pharmaceuticals
AMRX
$3.02B
| $9.62 | $5.50 |
43%
downside
| Market Perform | 4 years ago |
|
|
236
Progyny
PGNY
$1.94B
|
ST
Stephen Tanal
| $22.55 | $50 |
122%
upside
| Outperform | 4 years ago |
|
237
Molina Healthcare
MOH
$9.47B
|
ST
Stephen Tanal
| $174.65 | $255 |
46%
upside
| Outperform | 4 years ago |
|
238
Perrigo
PRGO
$3.12B
|
AF
Ami Fadia
| $22.65 | $63 |
178%
upside
| Outperform | 5 years ago |
|
239
Trevi Therapeutics
TRVI
$854M
| $7.01 | $9 |
28%
upside
| Outperform | 5 years ago |
|
|
240
Puma Biotechnology
PBYI
$253M
| $5.03 | $10 |
99%
upside
| Market Perform | 5 years ago |
|
|
241
Teva Pharmaceuticals
TEVA
$21.7B
| $18.95 | $14 |
26%
downside
| Market Perform | 5 years ago |
|
|
242
CONMED
CNMD
$1.7B
| $54.97 | $92 |
67%
upside
| Market Perform | 5 years ago |
|
|
|
AVDL
243
Avadel Pharmaceuticals
AVDL
$1.53B
|
AF
Ami Fadia
| $15.76 | $17 |
8%
upside
| Outperform | 5 years ago |
|
244
Baxter International
BAX
$12.5B
|
DA
Danielle Antalffy
| $24.42 | $105 |
330%
upside
| Outperform | 5 years ago |
|
245
Medtronic
MDT
$119B
|
RN
Richard Newitter
| $92.90 | $105 |
13%
upside
| Market Perform | 5 years ago |
|
246
Organogenesis Holdings
ORGO
$634M
| $5 | $9 |
80%
upside
| Outperform | 5 years ago |
|